Cue Biopharma, Inc.
CUE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645460
In the last 90 days, Cue Biopharma, Inc. insiders filed 0 open-market purchases and 3 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $52.2M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Cue Biopharma, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 49 | 2 | 57 | +10 |
| Shares | 21.8M | 3.02M | 21.4M | +2.62M (+13.9%) |
| Value | $6.67M | $921.0K | $4.95M | −$792.7K (−13.8%) |
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Cue Biopharma, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 2,457,452 | $565.2K | 0.00% |
| Vanguard Fiduciary Trust Co | 543,585 | $125.0K | 0.00% |
| Diadema Partners LP | 131,997 | $30.3K | 0.01% |
| Advisortrust Partners, LLC | 50,000 | $11.5K | 0.00% |
| Virtu Financial LLC | 49,553 | $11.0K | 0.00% |
| Persistent Asset Partners Ltd | 33,369 | $7.67K | 0.00% |
| Visionary Wealth Advisors | 29,285 | $6.73K | 0.00% |
| Gsa Capital Partners LLP | 20,341 | $5.00K | 0.00% |
| XTX Topco Ltd | 15,124 | $3.48K | 0.00% |
| Vanguard Global Advisers, LLC | 12,997 | $2.99K | 0.00% |
| Beacon Pointe Advisors, LLC | 10,000 | $2.30K | 0.00% |
| Dauntless Investment Group, LLC | 2,416 | $555 | 0.00% |
| Mather Group, LLC. | 1,000 | $230 | 0.00% |
| Advisory Services Network, LLC | 200 | $46 | 0.00% |
| Royal Bank of Canada | 75 | $0 | 0.00% |
Sold out (5)
Institutions that held Cue Biopharma, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Boothbay Fund Management, LLC | 704,297 | $215.1K |
| Jane Street Group, LLC | 69,793 | $21.3K |
| HRT Financial LP | 20,863 | $6.00K |
| HighTower Advisors, LLC | 10,929 | $3.34K |
| Torren Management, LLC | 324 | $99 |
Not filed for Q1 2026 yet (2)
Institutions that held Cue Biopharma, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 3,014,034 | $919.3K |
| New Millennium Group LLC | 5,750 | $1.76K |